Leila Alland M.D.
Net Worth

Last updated:

What is Leila Alland M.D. net worth?

The estimated net worth of Dr. Leila Alland M.D. is at least $3,247,839 as of 15 Sep 2023. He owns shares worth $72,504 as insider, has earned $656,655 from insider trading and has received compensation worth at least $2,518,680 in PMV Pharmaceuticals, Inc..

What is the salary of Leila Alland M.D.?

Dr. Leila Alland M.D. salary is $629,670 per year as Chief Medical Officer in PMV Pharmaceuticals, Inc..

How old is Leila Alland M.D.?

Dr. Leila Alland M.D. is 63 years old, born in 1962.

What stocks does Leila Alland M.D. currently own?

As insider, Dr. Leila Alland M.D. owns shares in one company:

Company Title Shares Price per share Total value
PMV Pharmaceuticals, Inc. (PMVP) Chief Medical Officer 45,909 $1.58 $72,504

What does PMV Pharmaceuticals, Inc. do?

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.

PMVP logo
PMVP
PMV Pharmaceuticals, Inc.
$1.58

Leila Alland M.D. insider trading

PMV Pharmaceuticals, Inc.

Dr. Leila Alland M.D. has made 9 insider trades between 2021-2023, according to the Form 4 filled with the SEC. Most recently he sold 6,291 units of PMVP stock worth $41,646 on 15 Sep 2023.

The largest trade he's ever made was exercising 6,291 units of PMVP stock on 15 Sep 2023. As of 15 Sep 2023 he still owns at least 45,909 units of PMVP stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 6,291 $6.62 $41,646
Option
Common Stock 100 $3.9 $390
Option
Employee Stock Option (right to buy) 100 $3.9 $390
Sale
Common Stock 100 $30.25 $3,025
Option
Common Stock 3,900 $3.9 $15,210
Sale
Common Stock 3,900 $30.25 $117,975
Option
Employee Stock Option (right to buy) 3,900 $3.9 $15,210
Sale
Common Stock 4,471 $34.8 $155,604
Option
Common Stock 4,000 $3.9 $15,600
Option
Employee Stock Option (right to buy) 4,000 $3.9 $15,600
Sale
Common Stock 4,000 N/A N/A
Option
Employee Stock Option (right to buy) 4,000 N/A N/A
Option
Common Stock 4,000 N/A N/A
Option
Common Stock 4,000 $3.9 $15,600
Option
Employee Stock Option (right to buy) 4,000 $3.9 $15,600
Sale
Common Stock 4,000 $33.7 $134,780
Sale
Common Stock 4,000 $33.7 $134,780
Option
Common Stock 4,000 N/A N/A
Option
Employee Stock Option (right to buy) 4,000 N/A N/A
Sale
Common Stock 4,000 N/A N/A
Sale
Common Stock 4,000 $17.21 $68,844
Option
Common Stock 4,000 $3.9 $15,600
Option
Employee Stock Option (right to buy) 4,000 N/A N/A

PMV Pharmaceuticals key executives

PMV Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: